Marie Arsenian-Henriksson

16PUBLICATIONS
107CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemCancer cell biologyInorganic materials (incl. nanomaterials)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 02, 2026
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.

|Jun 18, 2025
Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.

Judit Liaño-Pons, Elisa Garde-Lapido, Fenja L Fahrig

|Nov 16, 2024
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma.

Muhammad Mushtaq, Judit Liaño-Pons, Jiansheng Wang

|Aug 05, 2024
Defining neuroblastoma: From origin to precision medicine.

Lourdes Sainero-Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo

|Jun 21, 2024
MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma.

Elina Fredlund, Stina Andersson, Elien Hilgert

|Feb 29, 2024
A druggable conformational switch in the c-MYC transactivation domain.

Dilraj Lama, Thibault Vosselman, Cagla Sahin

Pageof 3

Frequent Collaborators

5 joint publications

Judit Liaño-Pons

3 joint publications

Sofie Mohlin

2 joint publications

Petra Bullova

2 joint publications

Jieyu Wu